Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Release
Share
Press Release
Apr 17, 2024
| Brian Hart
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?
Press Release
Feb 20, 2024
| Brian Hart
Medicare Plans Increase Patient Costs for Generic Medicines
Press Release
Feb 14, 2024
| Brian Hart
AAM Commends HHS and FTC Call for Information and Solutions on Drug Shortages and Patient Access to Generics and Biosimilars
Press Release
Feb 5, 2024
| Brian Hart
AAM White Paper: Hatch-Waxman Turns 40
Press Release
Jan 23, 2024
| Brian Hart
Keren Haruvi Named Chair of the Association for Accessible Medicines Board of Directors
Press Release
Jan 23, 2024
| Brian Hart
AAM Requests Federal Injunction to Block Illinois’ Unconstitutional Drug Price Law
Press Release
Dec 8, 2023
| Brian Hart
Keren Haruvi Announced as Chair of the Association for Accessible Medicines Board of Directors
Press Release
Nov 15, 2023
| Brian Hart
AAM Statement on IQVIA Institute Report Examining Drug Shortages
Press Release
Sep 6, 2023
| Monét Stanford
Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022
Press Release
Jul 5, 2023
| Susan Reilly
AAM Requests Federal Injunction to Block Minnesota’s Unconstitutional Drug Price Law
Press Release
May 15, 2023
| Susan Reilly
AAM Statement on U.S. Supreme Court Decision to Decline Hearing GSK v. Teva
Press Release
May 11, 2023
| Susan Reilly
4GRxANTED Campaign Generates Millions of Doses of Generic Medicine for Patients in Need
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
2024 Savings Report
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action